# ARREST 2 (NCT05508464)

> Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05508464
- Phase: NA
- Status: RECRUITING
- Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Conditions: Metastatic Cancer
- Interventions: Arm 2: SABR; Arm 1: Standard of Care
- Enrollment: 138
- Primary outcome: Overall Survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 11
- YouTube: 1
- Podcasts: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=arrest-2-nct05508464

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05508464", "email": "<work email>"}; the inbox owner confirms by the emailed link.